We are live on ! Find out more
OPRX icon

OptimizeRx

121 hedge funds and large institutions have $567M invested in OptimizeRx in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 34 increasing their positions, 36 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

438% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 8

326% more call options, than puts

Call options by funds: $44.1M | Put options by funds: $10.3M

83% more capital invested

Capital invested by funds: $310M → $567M (+$257M)

41% more funds holding

Funds holding: 86121 (+35)

2.96% more ownership

Funds ownership: 66%68.96% (+3%)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

6% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 36

Holders
121
Holders Change
+35
Holders Change %
+40.7%
% of All Funds
2.12%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
43
Increased
34
Reduced
36
Closed
8
Calls
$44.1M
Puts
$10.3M
Net Calls
+$33.8M
Net Calls Change
+$27.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Mirae Asset Global Investments
26
Mirae Asset Global Investments
South Korea
$5.43M +$1.14M +23,616 +27%
HI
27
Handelsinvest Investeringsforvaltning
Denmark
$5.36M -$482K -10,000 -8%
Marshall Wace
28
Marshall Wace
United Kingdom
$5.23M +$5.18M +107,256 New
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$5.11M +$3.95M +81,959 +366%
Calamos Advisors
30
Calamos Advisors
Illinois
$4.84M +$1.55M +32,049 +48%
HIM
31
Hillsdale Investment Management
Ontario, Canada
$4.65M +$4.6M +95,406 New
Goldman Sachs
32
Goldman Sachs
New York
$4.35M +$3.88M +80,404 +920%
CM
33
Castleark Management
Illinois
$4.33M +$4.29M +88,855 New
Swedbank
34
Swedbank
Sweden
$4.14M +$4.1M +84,960 New
SST
35
S Squared Technology
New York
$3.98M -$3.75M -77,798 -49%
Russell Investments Group
36
Russell Investments Group
United Kingdom
$3.75M +$1.26M +26,050 +51%
N
37
Nuveen
North Carolina
$3.44M +$186K +3,848 +6%
Bank of America
38
Bank of America
North Carolina
$3.31M +$1.54M +32,005 +89%
EI
39
EAM Investors
California
$2.13M -$4.43M -91,882 -68%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$2.09M -$13.8K -285 -0.7%
Wells Fargo
41
Wells Fargo
California
$1.98M +$448K +9,276 +30%
PAWC
42
P.A.W. Capital
Connecticut
$1.95M -$2.89M -60,000 -60%
Charles Schwab
43
Charles Schwab
California
$1.93M +$187K +3,867 +11%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$1.93M -$437K -9,067 -19%
Macquarie Group
45
Macquarie Group
Australia
$1.9M +$1.84M +38,182 +4,773%
PPA
46
Parametric Portfolio Associates
Washington
$1.83M +$1.81M +37,583 New
EGI
47
EAM Global Investors
California
$1.73M -$3.36M -69,563 -66%
ACA
48
Apis Capital Advisors
New York
$1.46M +$1.45M +30,000 New
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$1.46M
SEI Investments
50
SEI Investments
Pennsylvania
$1.4M +$1.44M +29,805 New

OPRX Hedge Fund Activity: Q1 2021 in Review

121 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2021, worth a combined $567M — up 83% from $310M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new OPRX positions and 8 closed out — a net gain of 35 holders — while 34 added to existing stakes and 36 trimmed.

The largest buyer was Artisan Partners, opening a new position worth an estimated $37.3M. The largest seller was AWM Investment Company, cutting an estimated $9.65M.

  • 121 institutional investors held OptimizeRx (OPRX) as of Q1 2021, up from 86 in Q4 2020.
  • Funds reported $567M of OptimizeRx stock for Q1 2021, up 83% quarter-over-quarter.
  • 43 funds opened new OptimizeRx positions in Q1 2021 and 8 closed out, a net change of +35 holders.
  • The largest OptimizeRx buyer in Q1 2021 was Artisan Partners, an estimated $37.3M added.
  • The largest OptimizeRx seller in Q1 2021 was AWM Investment Company, an estimated $9.65M sold.

Based on aggregated 13F filings for Q1 2021.